(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.

@article{Hulsteijn2014131IMIBGTF,
  title={(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.},
  author={Leonie Theresia van Hulsteijn and Nicolasine D. Niemeijer and Olaf Matthijs Dekkers and Eleonora P. M. Corssmit},
  journal={Clinical endocrinology},
  year={2014},
  volume={80 4},
  pages={487-501}
}
BACKGROUND (131)I-MIBG therapy can be used for palliative treatment of malignant paraganglioma and phaeochromocytoma. The main objective of this study was to perform a systematic review and meta-analysis assessing the effect of (131)I-MIBG therapy on tumour volume in patients with malignant paraganglioma/phaeochromocytoma. METHODS A literature search was performed in December 2012 to identify potentially relevant studies. Main outcomes were the pooled proportions of complete response, partial… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…